CuraSen Therapeutics
San Carlos
About CuraSen Therapeutics
CuraSen Therapeutics is a biopharmaceutical company that develops orphan drugs to treat neurodegenerative diseases, including Parkinson's disease, and Alzheimer's disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $101.7M
- Last round: Series Unknown (Sep 2024)
- Website: curasen.com
- Phone: 650-475-2842
Industries & Categories
Biotechnology, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/curasen-therapeutics-7083 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.